Mood-stabilizing drugs: Mechanisms of action

Robert J. Schloesser, Keri Martinowich, Husseini K. Manji

Research output: Contribution to journalReview articlepeer-review

Abstract

Mood-stabilizing drugs are the most widely prescribed pharmacological treatments for bipolar disorder, a disease characterized by recurrent episodes of mania and depression. Despite extensive clinical utilization, significant questions concerning their mechanisms of action remain. In recent years, a diverse set of molecular and cellular targets of these drugs has been identified. Based on these findings, downstream effects on neural and synaptic plasticity within key circuits have been proposed. Here, we discuss recent data, identify current challenges impeding progress and define areas for future investigation. Further understanding of the primary targets and downstream levels of convergence of mood-stabilizing drugs will guide development of novel therapeutic strategies and help translate discoveries into more effective treatments with less burdensome adverse-effect profiles.

Original languageEnglish (US)
Pages (from-to)36-46
Number of pages11
JournalTrends in neurosciences
Volume35
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Keywords

  • Bipolar disorder
  • Lithium
  • Mania
  • Mood-stabilizing drugs
  • Neurotrophic factors
  • Synaptic plasticity

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Mood-stabilizing drugs: Mechanisms of action'. Together they form a unique fingerprint.

Cite this